Advances in Pharma Business Management and Research : Volume 1 / / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen.
This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Me...
Saved in:
HerausgeberIn: | |
---|---|
Place / Publishing House: | Cham : : Springer International Publishing :, Imprint: Springer,, 2020. |
Year of Publication: | 2020 |
Edition: | 1st ed. 2020. |
Language: | English |
Physical Description: | 1 online resource (X, 85 p. 11 illus.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993544272204498 |
---|---|
ctrlnum |
(CKB)4100000010480423 (DE-He213)978-3-030-35918-8 (MiAaPQ)EBC6122108 (Au-PeEL)EBL6122108 (OCoLC)1143625864 (oapen)https://directory.doabooks.org/handle/20.500.12854/31058 (PPN)24298164X (EXLCZ)994100000010480423 |
collection |
bib_alma |
record_format |
marc |
spelling |
Schweizer, Lars edt Advances in Pharma Business Management and Research [electronic resource] : Volume 1 / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen. 1st ed. 2020. Springer Nature 2020 Cham : Springer International Publishing : Imprint: Springer, 2020. 1 online resource (X, 85 p. 11 illus.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Open access Unrestricted online access star Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management. This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business. Description based on publisher supplied metadata and other sources. English Pharmaceutical technology. Health care management. Health services administration. Medical laws and legislation. Pharmacy. Pharmacy management. Pharmaceutical Sciences/Technology. https://scigraph.springernature.com/ontologies/product-market-codes/B21010 Health Care Management. https://scigraph.springernature.com/ontologies/product-market-codes/527030 Medical Law. https://scigraph.springernature.com/ontologies/product-market-codes/R16005 Pharmacy. https://scigraph.springernature.com/ontologies/product-market-codes/F00008 Pharmacoeconomics and Health Outcomes. https://scigraph.springernature.com/ontologies/product-market-codes/H69020 Pharmaceutical Sciences/Technology Health Care Management Medical Law Pharmacy Pharmacoeconomics and Health Outcomes Pharmaceutics Health Care Pharmacology Pharma Management Market Access Regulatory Affairs Research & Development Quality Control Open Access Industrial chemistry & chemical engineering Health economics Medical & healthcare law Pharmacy / dispensing 3-030-35917-4 Schweizer, Lars. editor. edt http://id.loc.gov/vocabulary/relators/edt Dingermann, Theodor. editor. edt http://id.loc.gov/vocabulary/relators/edt Russe, Otto Quintus. editor. edt http://id.loc.gov/vocabulary/relators/edt Jansen, Christian. editor. edt http://id.loc.gov/vocabulary/relators/edt |
language |
English |
format |
Electronic eBook |
author2 |
Schweizer, Lars. Schweizer, Lars. Dingermann, Theodor. Dingermann, Theodor. Russe, Otto Quintus. Russe, Otto Quintus. Jansen, Christian. Jansen, Christian. |
author_facet |
Schweizer, Lars. Schweizer, Lars. Dingermann, Theodor. Dingermann, Theodor. Russe, Otto Quintus. Russe, Otto Quintus. Jansen, Christian. Jansen, Christian. |
author2_variant |
l s ls l s ls l s ls t d td t d td o q r oq oqr o q r oq oqr c j cj c j cj |
author2_role |
HerausgeberIn HerausgeberIn HerausgeberIn HerausgeberIn HerausgeberIn HerausgeberIn HerausgeberIn HerausgeberIn |
author_sort |
Schweizer, Lars. |
title |
Advances in Pharma Business Management and Research Volume 1 / |
spellingShingle |
Advances in Pharma Business Management and Research Volume 1 / Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management. |
title_sub |
Volume 1 / |
title_full |
Advances in Pharma Business Management and Research [electronic resource] : Volume 1 / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen. |
title_fullStr |
Advances in Pharma Business Management and Research [electronic resource] : Volume 1 / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen. |
title_full_unstemmed |
Advances in Pharma Business Management and Research [electronic resource] : Volume 1 / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen. |
title_auth |
Advances in Pharma Business Management and Research Volume 1 / |
title_new |
Advances in Pharma Business Management and Research |
title_sort |
advances in pharma business management and research volume 1 / |
publisher |
Springer Nature Springer International Publishing : Imprint: Springer, |
publishDate |
2020 |
physical |
1 online resource (X, 85 p. 11 illus.) |
edition |
1st ed. 2020. |
contents |
Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management. |
isbn |
3-030-35918-2 3-030-35917-4 |
callnumber-first |
R - Medicine |
callnumber-subject |
RS - Pharmacy |
callnumber-label |
RS380 |
callnumber-sort |
RS 3380 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
615 - Pharmacology & therapeutics |
dewey-full |
615.19 |
dewey-sort |
3615.19 |
dewey-raw |
615.19 |
dewey-search |
615.19 |
oclc_num |
1143625864 |
work_keys_str_mv |
AT schweizerlars advancesinpharmabusinessmanagementandresearchvolume1 AT dingermanntheodor advancesinpharmabusinessmanagementandresearchvolume1 AT russeottoquintus advancesinpharmabusinessmanagementandresearchvolume1 AT jansenchristian advancesinpharmabusinessmanagementandresearchvolume1 |
status_str |
n |
ids_txt_mv |
(CKB)4100000010480423 (DE-He213)978-3-030-35918-8 (MiAaPQ)EBC6122108 (Au-PeEL)EBL6122108 (OCoLC)1143625864 (oapen)https://directory.doabooks.org/handle/20.500.12854/31058 (PPN)24298164X (EXLCZ)994100000010480423 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Advances in Pharma Business Management and Research Volume 1 / |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField |
_version_ |
1787548899980869632 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05293nam a22008775i 4500</leader><controlfield tag="001">993544272204498</controlfield><controlfield tag="005">20230822223102.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr#nn#008mamaa</controlfield><controlfield tag="008">200219s2020 gw | o |||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-030-35918-2</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-030-35918-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000010480423</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-He213)978-3-030-35918-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)EBC6122108</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL6122108</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1143625864</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/31058</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PPN)24298164X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000010480423</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS380</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS190-210</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">TDCW</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED072000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">TDC</subfield><subfield code="2">thema</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">615.19</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schweizer, Lars</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances in Pharma Business Management and Research</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">Volume 1 /</subfield><subfield code="c">edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2020.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Springer Nature</subfield><subfield code="c">2020</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing :</subfield><subfield code="b">Imprint: Springer,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (X, 85 p. 11 illus.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical technology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Health care management.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Health services administration.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical laws and legislation.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacy.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacy management.</subfield></datafield><datafield tag="650" ind1="1" ind2="4"><subfield code="a">Pharmaceutical Sciences/Technology.</subfield><subfield code="0">https://scigraph.springernature.com/ontologies/product-market-codes/B21010</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Health Care Management.</subfield><subfield code="0">https://scigraph.springernature.com/ontologies/product-market-codes/527030</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Medical Law.</subfield><subfield code="0">https://scigraph.springernature.com/ontologies/product-market-codes/R16005</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Pharmacy.</subfield><subfield code="0">https://scigraph.springernature.com/ontologies/product-market-codes/F00008</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Pharmacoeconomics and Health Outcomes.</subfield><subfield code="0">https://scigraph.springernature.com/ontologies/product-market-codes/H69020</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmaceutical Sciences/Technology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health Care Management</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medical Law</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmacy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmacoeconomics and Health Outcomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmaceutics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health Care</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmacology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharma Management</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Market Access</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Regulatory Affairs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Research & Development</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Quality Control</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Open Access</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Industrial chemistry & chemical engineering</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health economics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medical & healthcare law</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pharmacy / dispensing</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-030-35917-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schweizer, Lars.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dingermann, Theodor.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Russe, Otto Quintus.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jansen, Christian.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-08-24 03:06:04 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-03-09 01:44:44 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337594190004498&Force_direct=true</subfield><subfield code="Z">5337594190004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337594190004498</subfield></datafield></record></collection> |